Add Yahoo as a preferred source to see more of our stories on Google. An illustration depicts cells in an Alzheimer's-affected brain, with abnormal levels of beta amyloid protein clumping together to ...

Transthyretin amyloid cardiomyopathy (ATTR-CM) is a disease that causes a blood protein called transthyretin (TTR) to build up in your heart, nerves, and potentially other organs. TTR proteins aren’t ...

Medically reviewed by Jeffrey S. Lander, MD Transthyretin amyloid cardiomyopathy (ATTR-CM) causes the heart to be stiff and ...

Preliminary results from a landmark clinical trial to prevent Alzheimer's disease (AD) symptoms show that an investigational anti-amyloid drug, solanezumab, did not demonstrate a statistically ...

Randall J. Bateman, MD, the Charles F. and Joanne Knight Distinguished Professor of Neurology at WashU Medicine, is the study director of an international clinical trial that finds an anti-amyloid ...

Higher initial amyloid levels in certain brain regions of older adults with no cognitive or psychiatric symptoms at baseline are associated with greater informant-rated but not self-rated apathy at ...

Please provide your email address to receive an email when new articles are posted on . Depressive symptoms may be an early feature of preclinical Alzheimer’s disease. Associations between increasing ...

In Alzheimer's disease, amyloid plaques form in the brain, followed by threadlike structures made of the protein tau. Both changes have toxic effects on the brain's nerve cells years before dementia ...

Hereditary transthyretin amyloid cardiomyopathy (hATTR-CM) is an inherited heart condition in which protein buildup in the heart muscle causes it to stiffen and thicken, often leading to heart failure ...

The new study, published Wednesday in the journal Lancet Neurology, found that the risk of symptoms was cut in half for a small subset of 22 patients who had not shown any problems with memory or ...